Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)

被引:13
作者
Calleja, Jose L. [1 ]
Macias, Juan [2 ,3 ]
Forns, Xavier [4 ]
Garcia, Federico [3 ,5 ]
Berenguer, Marina [6 ]
Garcia Deltoro, Miguel [3 ,7 ]
Buti, Maria [8 ]
Granados, Rafael [3 ,9 ]
Carrion, Jose A. [10 ]
Morano, Luis [3 ,11 ]
Fernandez, Inmaculada [12 ]
Coste, Pablo [1 ]
Pineda, Juan A. [2 ,3 ]
机构
[1] Univ Autonoma Madrid, Hosp Univ Puerta De Hierro, Inst Invest Puerta De Hierro, Serv Gastroenterol & Hepatol, Madrid, Spain
[2] Hosp Univ Valme, Unidad Enfermedades Infecciosas & Microbiol, Seville, Spain
[3] Soc Espanola Enfermedades Infecciosas & Microbiol, Grp Estudio Hepatitis Vir, Madrid, Spain
[4] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Serv Hepatol,Hosp Clin, Barcelona, Spain
[5] Hosp Univ San Cecilio, Inst Invest Biosanitaria Ibs, Red Invest SIDA Ret ISCiii RD16 0025, Unidad Gest Clin Microbiol, Granada, Spain
[6] Univ Valencia, Hosp Univ & Politecn La Fe, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Unidad Hepatol,IIS La Fe, Valencia, Spain
[7] Consorcio Hosp Gen Univ Valencia, Serv Enfermedades Infecciosas, Valencia, Spain
[8] Hosp Univ Vall dHebron, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Serv Hepatol, Barcelona, Spain
[9] Hosp Univ Gran Canaria Dr Negrin, Unidad Enfermedades Infecciosas, Serv Med Interna, Las Palmas Gran Canaria, Spain
[10] Univ Autonoma Barcelona, Hosp del Mar, Inst Hosp del Mar Invest Med IMIM, Secc Hepatol,Serv Digest, Barcelona, Spain
[11] Univ Santiago de Compostela, Hosp Univ Alvaro Cunqueiro, Unidad Patol Infecciosa, IISGS, Vigo, Pontevedra, Spain
[12] Hosp Univ 12 Octubre, Unidad Hepatol, Madrid, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2018年 / 41卷 / 09期
关键词
HCV GENOTYPE 1; CHRONIC KIDNEY-DISEASE; TREATMENT-EXPERIENCED PATIENTS; LEDIPASVIR PLUS SOFOSBUVIR; ACTING ANTIVIRAL THERAPY; OPEN-LABEL; TREATMENT-NAIVE; SINGLE-ARM; COMPENSATED CIRRHOSIS; CLINICAL-OUTCOMES;
D O I
10.1016/j.gastrohep.2018.07.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:597 / 608
页数:12
相关论文
共 56 条
  • [1] Ledipasvir Plus Sofosbuvir for 12 Weeks in Patients With Hepatitis C Genotype 4 Infection
    Abergel, Armand
    Metivier, Sophie
    Samuel, Didier
    Jiang, Deyuan
    Kersey, Kathryn
    Pang, Phillip S.
    Svarovskaia, Evguenia
    Knox, Steven J.
    Loustaud-Ratti, Veronique
    Asselah, Tarik
    [J]. HEPATOLOGY, 2016, 64 (04) : 1049 - 1056
  • [2] Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study
    Abergel, Armand
    Asselah, Tarik
    Metivier, Sophie
    Kersey, Kathryn
    Jiang, Deyuan
    Mo, Hongmei
    Pang, Phillip S.
    Samuel, Didier
    Loustaud-Ratti, Veronique
    [J]. LANCET INFECTIOUS DISEASES, 2016, 16 (04) : 459 - 464
  • [3] Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
    Afdhal, Nezam
    Zeuzem, Stefan
    Kwo, Paul
    Chojkier, Mario
    Gitlin, Norman
    Puoti, Massimo
    Romero-Gomez, Manuel
    Zarski, Jean-Pierre
    Agarwal, Kosh
    Buggisch, Peter
    Foster, Graham R.
    Braeu, Norbert
    Buti, Maria
    Jacobson, Ira M.
    Subramanian, G. Mani
    Ding, Xiao
    Mo, Hongmei
    Yang, Jenny C.
    Pang, Phillip S.
    Symonds, William T.
    McHutchison, John G.
    Muir, Andrew J.
    Mangia, Alessandra
    Marcellin, Patrick
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (20) : 1889 - 1898
  • [4] Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients
    Agarwal, Kosh
    Castells, Lluis
    Mullhaupt, Beat
    Rosenberg, William M. C.
    McNabb, Brian
    Arterburn, Sarah
    Camus, Gregory
    McNally, John
    Stamm, Luisa M.
    Brainard, Diana M.
    Subramanian, G. Mani
    Marino, Zoe
    Dufour, Jean-Francois
    Forns, Xavier
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (03) : 603 - 607
  • [5] Asselah T, 2018, INT LIV C PAR 11 15
  • [6] Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis
    Asselah, Tarik
    Reesink, Hendrik
    Gerstoft, Jan
    de Ledinghen, Victor
    Pockros, Paul J.
    Robertson, Michael
    Hwang, Peggy
    Asante-Appiah, Ernest
    Wahl, Janice
    Nguyen, Bach-Yen
    Barr, Eliav
    Talwani, Rohit
    Serfaty, Lawrence
    [J]. LIVER INTERNATIONAL, 2018, 38 (09) : 1583 - 1591
  • [7] Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
    Asselah, Tarik
    Bourgeois, Stefan
    Pianko, Stephen
    Zeuzem, Stefan
    Sulkowski, Mark
    Foster, Graham R.
    Han, Lingling
    McNally, John
    Osinusi, Anu
    Brainard, Diana M.
    Subramanian, G. Mani
    Gane, Edward J.
    Feld, Jordan J.
    Mangia, Alessandra
    [J]. LIVER INTERNATIONAL, 2018, 38 (03) : 443 - 450
  • [8] Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
    Asselah, Tarik
    Kowdley, Kris V.
    Zadeikis, Neddie
    Wang, Stanley
    Hassanein, Tarek
    Horsmans, Yves
    Colombo, Massimo
    Calinas, Filipe
    Aguilar, Humberto
    de Ledinghen, Victor
    Mantry, Parvez S.
    Hezode, Christophe
    Marinho, Rui Tato
    Agarwal, Kosh
    Nevens, Frederik
    Elkhashab, Magdy
    Kort, Jens
    Liu, Ran
    Ng, Teresa I.
    Krishnan, Preethi
    Lin, Chih-Wei
    Mensa, Federico J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (03) : 417 - 426
  • [9] Belli LS, 2018, J HEPATOL S, VS0168-8278, P32163
  • [10] Boesecke C, 2017, C RETR OPP INF SEATT